Pfeiffer R, Kirsch J, Fahrenholz F
Institut für Biochemie der Universität Mainz, Joachim-Becher-Weg 30, Mainz, 55099, Germany.
Exp Cell Res. 1998 Oct 10;244(1):327-39. doi: 10.1006/excr.1998.4159.
In this report we demonstrate that in HEK293 cells stably expressing the human V2 vasopressin receptor, ligand-induced internalization of the hormone receptor occurs via the clathrin-dependent pathway. Studies of receptor trafficking either by direct visualization of the V2 receptor by confocal microscopy or binding experiments show a rapid internalization (half-time 6-7 min). Blocking of the clathrin-dependent pathway by hypertonic sucrose increased vasopressin-induced cellular cAMP production and decreased the desensitization of the V2 receptor-adenylyl cyclase system. Thus, internalization appears to be a major regulatory mechanism terminating vasopressin action in HEK293 cells. Two antagonists of the vasopressin V2 receptor exerted different effects on receptor internalization, as determined by confocal fluorescence microscopy. The nonpeptidic antagonist OPC31260 did not induce any visible receptor internalization, whereas the peptidic antagonist d(CH2)5[D-Tyr(Et)2,Val4,Lys8,Tyr-NH29]VP induced a slow but substantial receptor internalization. These results suggest that long-term treatment with peptidic V2 receptor antagonists might lead to desensitization.
在本报告中,我们证明,在稳定表达人V2血管加压素受体的HEK293细胞中,激素受体的配体诱导内化通过网格蛋白依赖途径发生。通过共聚焦显微镜直接观察V2受体或结合实验对受体转运的研究显示出快速内化(半衰期6 - 7分钟)。用高渗蔗糖阻断网格蛋白依赖途径可增加血管加压素诱导的细胞cAMP产生,并降低V2受体 - 腺苷酸环化酶系统的脱敏作用。因此,内化似乎是终止HEK293细胞中血管加压素作用的主要调节机制。通过共聚焦荧光显微镜测定,血管加压素V2受体的两种拮抗剂对受体内化产生不同影响。非肽类拮抗剂OPC31260未诱导任何可见的受体内化,而肽类拮抗剂d(CH2)5[D-Tyr(Et)2,Val4,Lys8,Tyr-NH29]VP诱导缓慢但显著的受体内化。这些结果表明,长期用肽类V2受体拮抗剂治疗可能导致脱敏。